Mayinglong Hemorrhoids
NDC Package 68511-993-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Mayinglong Hemorrhoids is a medication used as AstrigentProtectantProtectant. Marketed by Mayinglong Pharmaceutical Group Co Ltd, this product is identified by NDC 68511-993 and is authorized under FDA application part346.

Identification & Billing

NDC Package Code
68511-993-01
Package Description
10000 mg in 1 CARTON
Product Code
11-Digit Billing Format
68511099301
Billing Unit
GM - Billing unit of "gram" is used when a product is measured by its weight.
Units Per Package
10 GM
RxNorm Crosswalk
  • RxCUI: 2058531 - petrolatum 78.5 % / zinc oxide 8 % Topical Ointment
  • RxCUI: 2058531 - petrolatum 0.785 MG/MG / zinc oxide 0.08 MG/MG Topical Ointment
  • RxCUI: 2058531 - Petrolatum 0.785 MG/MG / ZNO 0.08 MG/MG Topical Ointment

Clinical Specifications

Proprietary Name
Mayinglong Hemorrhoids
Dosage Form
-
Usage Information
This product is used as AstrigentProtectantProtectant. Helps relieve the local itching and discomfort associated with hemorrhoidstemporarily shrinks hemorrhoidal tissue and relieves burningtemporarily provides a coating for relief of anorectal discomfortstemporarily protects the inflamed, irritated anorectal surface to help make bowel movements less painful

Regulatory & Marketing

Labeler Name
Mayinglong Pharmaceutical Group Co Ltd
FDA Application #
part346
Marketing Category
OTC MONOGRAPH FINAL - A product marketed pursuant to a final Over-the-Counter (OTC) Drug Monograph.
Start Marketing Date
12-15-2003
Listing Expiration
12-31-2020
Exclude Flag
I
Sample Package
No

Hierarchy Structure

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (68511-993). Click a package code to view its specific billing and regulatory data.

10000 mg in 1 CARTON
4000 mg in 1 CARTON
20000 mg in 1 CARTON

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 68511-993-01 identifies a specific commercial package of 10000 mg in 1 carton of Mayinglong Hemorrhoids, labeled by Mayinglong Pharmaceutical Group Co Ltd. This product is billed per "GM" gram and contains an estimated amount of 10 billable units per package. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Mayinglong Pharmaceutical Group Co Ltd on December 15, 2003. The current certification is valid through December 31, 2020.

How is this Mayinglong Pharmaceutical Group Co Ltd product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 68511099301. Quantities are measured in per "gm or gram", products billed per gram are products measured by weight.. There are 10 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
68511-993-01
11-Digit CMS (5-4-2)
68511-0993-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.